These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 14927797)

  • 1. The use of adjuvants in studies on influenza immunization. I. Measurements in monkeys of the dimensions of antigenicity of virus-mineral oil emulsions.
    SALK JE; LAURENT AM
    J Exp Med; 1952 May; 95(5):429-47. PubMed ID: 14927797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of adjuvants in studies on influenza immunization. II. Increased antibody formation in human subjects inoculated with influenza virus vaccine in a water in-oil emulsion.
    SALK JE; BAILEY ML; LAURENT AM
    Am J Hyg; 1952 May; 55(3):439-56. PubMed ID: 14933383
    [No Abstract]   [Full Text] [Related]  

  • 3. A novel non-mineral oil-based adjuvant. II. Efficacy of a synthetic sulfolipopolysaccharide in a squalane-in-water emulsion in pigs.
    Hilgers LA; Platenburg PL; Luitjens A; Groenveld B; Dazelle T; Weststrate MW
    Vaccine; 1994 May; 12(7):661-5. PubMed ID: 8085386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a novel oil-in-water emulsion and evaluation of its potential adjuvant function in a swine influenza vaccine in mice.
    Zhang J; Miao J; Han X; Lu Y; Deng B; Lv F; Zhao Y; Ding C; Hou J
    BMC Vet Res; 2018 Dec; 14(1):415. PubMed ID: 30577861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody response and reactions to aqueous influenza vaccine, simple emulsion vaccine and multiple emulsion vaccine. A report to the Medical Research Council Committee on influenza and other respiratory virus vaccines.
    Taylor PJ; Miller CL; Pollock TM; Perkins FT; Westwood MA
    J Hyg (Lond); 1969 Sep; 67(3):485-90. PubMed ID: 4897544
    [No Abstract]   [Full Text] [Related]  

  • 6. Adjuvant influenza vaccines.
    Stuart-Harris CH
    Bull World Health Organ; 1969; 41(3):617-21. PubMed ID: 5309486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a novel oil-in-water emulsion adjuvant for swine influenza virus and Mycoplasma hyopneumoniae vaccines.
    Galliher-Beckley A; Pappan LK; Madera R; Burakova Y; Waters A; Nickles M; Li X; Nietfeld J; Schlup JR; Zhong Q; McVey S; Dritz SS; Shi J
    Vaccine; 2015 Jun; 33(25):2903-8. PubMed ID: 25936722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasally administered Endocine formulated 2009 pandemic influenza H1N1 vaccine induces broad specific antibody responses and confers protection in ferrets.
    Maltais AK; Stittelaar KJ; Veldhuis Kroeze EJ; van Amerongen G; Dijkshoorn ML; Krestin GP; Hinkula J; Arwidsson H; Lindberg A; Osterhaus AD
    Vaccine; 2014 May; 32(26):3307-15. PubMed ID: 24690149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel non-mineral oil-based adjuvant. I. Efficacy of a synthetic sulfolipopolysaccharide in a squalane-in-water emulsion in laboratory animals.
    Hilgers LA; Platenburg PL; Luitjens A; Groenveld B; Dazelle T; Ferrari-Laloux M; Weststrate MW
    Vaccine; 1994 May; 12(7):653-60. PubMed ID: 8085385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbohydrate fatty acid monosulphate esters are safe and effective adjuvants for humoral responses.
    Hilgers LAT; Platenburg PPLI; Bajramovic J; Veth J; Sauerwein R; Roeffen W; Pohl M; van Amerongen G; Stittelaar KJ; van den Bosch JF
    Vaccine; 2017 May; 35(24):3249-3255. PubMed ID: 28479181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice.
    Wack A; Baudner BC; Hilbert AK; Manini I; Nuti S; Tavarini S; Scheffczik H; Ugozzoli M; Singh M; Kazzaz J; Montomoli E; Del Giudice G; Rappuoli R; O'Hagan DT
    Vaccine; 2008 Jan; 26(4):552-61. PubMed ID: 18162266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the adjuvant effect of water-in-oil-in-water (w/o/w) emulsion of sesame oil. 1. Enhanced and persistent antibody formation by antigen incorporated into the water-in-oil-in-water emulsion.
    Kimura J; Nariuchi H; Watanabe T; Matuhasi T; Okayasu I; Hatakeyama S
    Jpn J Exp Med; 1978 Apr; 48(2):149-54. PubMed ID: 713123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technology transfer of oil-in-water emulsion adjuvant manufacturing for pandemic influenza vaccine production in Romania: Preclinical evaluation of split virion inactivated H5N1 vaccine with adjuvant.
    Stavaru C; Onu A; Lupulescu E; Tucureanu C; Rasid O; Vlase E; Coman C; Caras I; Ghiorghisor A; Berbecila L; Tofan V; Bowen RA; Marlenee N; Hartwig A; Bielefeldt-Ohmann H; Baldwin SL; Van Hoeven N; Vedvick TS; Huynh C; O'Hara MK; Noah DL; Fox CB
    Hum Vaccin Immunother; 2016 Apr; 12(4):1009-26. PubMed ID: 26618392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the adjuvant activity of emulsions with different physicochemical properties on the antibody response towards the venom of West African carpet viper (Echis ocellatus).
    Valverde JM; Rodríguez K; Herrera M; Segura Á; Vargas M; Villalta M; Montero M; Gutiérrez JM; León G
    Toxicon; 2017 Mar; 127():106-111. PubMed ID: 28088478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunogenicity-enhancing effect of emulsion vaccine adjuvants is independent of the dispersion type and antigen release rate--a revisit of the role of the hydrophile-lipophile balance (HLB) value.
    Yang YW; Wei AC; Shen SS
    Vaccine; 2005 Apr; 23(20):2665-75. PubMed ID: 15780450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of identity in neutralizing and hemagglutination-inhibiting antibodies against influenza viruses.
    WALKER DL; HORSFALL FL
    J Exp Med; 1950 Jan; 91(1):65-86. PubMed ID: 15395574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of recombinant flagellin in oil-in-water emulsions enhances hemagglutinin-specific mucosal IgA production and IL-17 secreting T cells against H5N1 avian influenza virus infection.
    Lai CH; Tang N; Jan JT; Huang MH; Lu CY; Chiang BL; Huang LM; Wu SC
    Vaccine; 2015 Aug; 33(35):4321-9. PubMed ID: 25858857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
    de Haan A; Haijema BJ; Voorn P; Meijerhof T; van Roosmalen ML; Leenhouts K
    Vaccine; 2012 Jul; 30(32):4884-91. PubMed ID: 22537989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stable emulsion (SE) alone is an effective adjuvant for a recombinant, baculovirus-expressed H5 influenza vaccine in healthy adults: A Phase 2 trial.
    Treanor JJ; Chu L; Essink B; Muse D; El Sahly HM; Izikson R; Goldenthal KL; Patriarca P; Dunkle LM
    Vaccine; 2017 Feb; 35(6):923-928. PubMed ID: 28089141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the antigenicity of an inactivated, aluminum hydroxide adjuvant equine influenza vaccine.
    Kucera CJ; Beckenhauer WH
    Can J Comp Med; 1977 Jul; 41(3):326-31. PubMed ID: 20211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.